|
JBJS welcomes reader comments on published articles. Letters to the Editor are reviewed by JBJS editors but are not peer-reviewed. To submit your letter, please follow the "submit a response" link that appears in the content box at the upper right of the full text of the article.
Letters to the Editor to:
-
- Scientific Articles:
Daniel S. Horwitz, Kathryn L.S. Schabel, and Thomas F. Higgins
- The Economic Impact of Reprocessing External Fixation Components
J Bone Joint Surg Am 2007; 89: 2132-2136
[Abstract]
[Full text]
[PDF]
|
|
Electronic letters published:
-
Dr. Higgins et al. respond to Dr. Riley.
- Thomas F Higgins, M.D., Daniel S. Horwitz, M.D., Kathryn L.S. Schabel, M.D.
(6 February 2008)
-
Economic and Environmental Impact of Orthopaedic Surgery
- Diane C. Riley, M.D.
(16 January 2008)
-
Reprocessing External Fixation Components
- Daniel J Vukelich
(10 January 2008)
-
Dr. Higgins replies to Mr. Vukelich
- Thomas F Higgins, M.D.
(10 January 2008)
|
Dr. Higgins et al. respond to Dr. Riley. |
6 February 2008 |
|
|
Thomas F Higgins, M.D., Assistant Professor University of Utah, Dept. of Orthopaedics, Salt Lake City, Utah, Daniel S. Horwitz, M.D., Kathryn L.S. Schabel, M.D.
Send letter to journal:
Re: Dr. Higgins et al. respond to Dr. Riley.
thomas.higgins{at}hsc.utah.edu Thomas F Higgins, M.D., et al.
|
We appreciate Dr. Riley’s feedback on our study(1). Her point is well
taken--our paper(1) focused mostly on the economic impact, but
environmental impact must be assessed as well.
The trend toward single use devices may be largely driven by
financial and industry concerns, but in many cases there is little reason
not to salvage much of what is used in the operating room. As surgeons
and citizens, we are obliged to consider our environmental impact and
assess the true resource cost of that which we consume.
As with many environmental concerns, establishing economic incentives
may be the best way to insure improved environmental stewardship.
Hopefully programs, such as the one examined in this study, may be a step
toward demonstrating the viability of such incentives.
Reference:
1. Horwitz DS, Schabel KLS, Higgins TF. The economic impact of processing external fixation components. J Bone Joint Surg Am. 2007;89:2132-2136. |
|
Economic and Environmental Impact of Orthopaedic Surgery |
16 January 2008 |
|
|
Diane C. Riley, M.D. Mt. Ascutney Hospital, Windsor, VT
Send letter to journal:
Re: Economic and Environmental Impact of Orthopaedic Surgery
vermonthand{at}gmail.com Diane C. Riley, M.D.
|
To The Editor:
Dr. Horwitz and his colleagues are to be commended for their study. The
health care sector comprises 16% of our GDP. Twenty-five per cent of hospital waste comes
from the operating room and much of that is red bag waste, i.e., waste that is
ten times more expensive to dispose of. Because of our need for
fixation devices, orthopaedics has large resource needs.
It has struck me
as inane that drill bits or used screws are discarded. Dr. Horwitz et
al. recognized the benefits of a products "life-cycle assessment". They proposed that the manufacturer has a responsibility for disposing of the
products they produce; and they created an opportunity for themselves as well
as for the producer. By repurchasing a product from the manufacturer at a reduced cost they not only saved money, but
diverted the product from their most expensive waste stream. Stryker, the
company in question, avoided losing business to a third party
reprocesser by recycling components – a process that uses less energy than
virgin product production.
None need to be told of the concern regarding the increasing costs of
orthopaedic implants. This paper(1) shows that if we start asking questions
of our manufacturing colleagues, we can create opportunities to decrease
our implant costs through recycling programs. Although not mentioned in
the paper(1), such programs can also lead to decreased waste costs. When we
look at new products, we should ask manufacturers to reprocess or recycle old
product, provide autoclavable containers, and to use recycled metals in
their products.
New developments in Orthopaedics are exciting, but it seems that we
are moving away from designing reusable items and moving towards more
single use items. None of us wishes to compromise our results with
substandard equipment but does that mean each implant or product needs to be used only once? It is my hope that articles such as this can
help us understand the economic and environmental impact of surgery and
how to make it a more sustainable field.
The author did not receive any outside funding or grants in support of her research for or preparation of this work. Neither she nor a member of her immediate family received payments or other benefits or a commitment or agreement to provide such benefits from a commercial entity. No commercial entity paid or directed, or agreed to pay or direct, any benefits to any research fund, foundation, division, center, clinical practice, or other charitable or nonprofit organization with which the author, or a member of her immediate family, is affiliated or associated.
Reference:
1. Horwitz DS, Schabel KLS, Higgins TF. The economic impact of reprocessing external fixation components. J Bone Joint Surg Am. 2007;89:2132-2136. |
|
Reprocessing External Fixation Components |
10 January 2008 |
|
|
Daniel J Vukelich, Executive Director Association of Medical Device Reprocessors
Send letter to journal:
Re: Reprocessing External Fixation Components
dvukelich{at}amdr.org Daniel J Vukelich
|
To The Editor:
I read with interest the article, The Economic Impact of Reprocessing
External Fixation Components(1). As Executive Director
of the Association of Medical Device Reprocessors (AMDR), the trade
association that represents third-party reprocessors of medical devices, I
was pleased to see the article confirm what our industry has demonstrated
for many years-- that reprocessed external fixation devices are safe and
effective. However, AMDR discovered errors and false assumptions about
the third-party reprocessing industry in the article. A summary of our concerns is listed below:
The authors highlight an example of an original equipment
manufacturer (OEM) reprocessing its own "single use" devices, confirming
once again that "single use" doesn't always mean just that. Indeed, the
reprocessing of devices labeled for "single use" has been standard
practice in U.S. hospitals for years. Reprocessing emerged when hospitals noted that
OEM's had begun to change the labels on devices from "reusable" to
"single use," without making significant design, performance, or material
changes to the devices. It became clear that this practice was often
motivated by economic objectives rather than patient safety concerns.
Third party reprocessing of “single use” devices (SUDs) is
fully regulated by the Food and Drug Administration (FDA). Reprocessed
devices marketed in the U.S. are as safe and as effective as original
equipment. AMDR’s members serve all of the top ten heart hospitals and
all of the top ten orthopedic hospitals in the nation, as ranked by U.S.
News & World Report. Overall, we serve 17 of the nation’s 18 “Honor
Roll” hospitals.
The nation’s third-party reprocessors have accomplished all
this while maintaining a stellar safety record. Unlike OEMs who may test
or inspect only a sampling of the devices they produce, AMDR’s members test or
inspect 100 percent of the devices they reprocess. AMDR’s members are
also committed to complete device traceability. Each reprocessed device is
marked or otherwise designated so that users know it is reprocessed, and
our tracing mechanisms track how many times each device has been
reprocessed.
The reprocessing industry has safely reprocessed over 50 million
devices and prevented over 10,000 tons of medical waste from entering our
landfills. No other segment of the medical device industry is helping
hospitals reduce waste and costs like the third-party reprocessors.
A more detailed response by AMDR to this article is available at www.amdr.org.
The authors did not receive any outside funding or grants in support of their research for or preparation of this work. One or more of the authors, or a member of his or her immediate family, received, in any one year, payments or other benefits in excess of $10,000 or a commitment or agreement to provide such benefits from a commercial entity (Association of Medical Device Reprocessors - AMDR). No commercial entity paid or directed, or agreed to pay or direct, any benefits to any research fund, foundation, division, center, clinical practice, or other charitable or nonprofit organization with which the authors, or a member of their immediate families, are affiliated or associated.
Reference:
1. Horwitz DS, Schabel KLS, Higgins TF. The economic impact of reprocessing external fixation components. J Bone Joint Surg Am. 2007;89:2132-2136. |
|
Dr. Higgins replies to Mr. Vukelich |
10 January 2008 |
|
|
Thomas F Higgins, M.D., Assistant Professor University of Utah, Department of Orthopaedics, Salt Lake City, Utah
Send letter to journal:
Re: Dr. Higgins replies to Mr. Vukelich
thomas.Higgins{at}hsc.utah.edu Thomas F Higgins, M.D.
|
We appreciate Mr. Vulkelich’s interest in our research. We welcome
his
feedback on behalf the Association of Medical Device Reprocessors, a trade
organization he directs to promote third party re-processing. He reports,
however, that there are “errors and false assumptions” in the article, and
we
are happy to respond to these claims below.
Mr. Vulkelich asserts that single use devices may be re-used, a point
which is
the very basis of our article. Next he asserts that third party
reprocessing is
regulated by the FDA, a point also stated in our article. Finally, he
states
that original equipment manufacturers only inspect and test a sample of
the
reprocessed product, while third party re-processors test 100 percent and
mark each device for the number of cycles it has undergone. A thorough
reading of the materials and methods section of our paper reveals that
each
piece of equipment was inspected and tested, and etched with a marking for
each time it was re-processed (1).
We were also referred to the AMDR website. Here they further claim
that our
report that carbon fiber components were not being re-certified is
incorrect,
pointing out FDA clearance was obtained as of December, 2007. Our article
was published in October, 2007, at which time our statement was accurate.
Our paper was meant to provide an economic analysis of potential cost
savings associated with external fixation reprocessing by the original
manufacturer. This was not done at the behest of industry, but rather as
an
academic search for answers and possible savings.
Further claims are made as to the stellar safety record of third
party
reprocessors. If Mr. Vukelich wishes to study and publish the cost savings
and safety of third party reprocessing of external fixation components, we
believe this would be a valuable addition to the literature.
Reference:
1. Horwitz DS, Schabel KLS, Higgins TF. The economic impact of reprocessing external fixation components. J Bone Joint Surg Am. 2007;89:2133. |
|